Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 17, keine Gesamtzahl für „section“
Suchtreffer
Begriffe & Kennungen
Brilique · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 (see section 4.8)
Eintrag öffnenBrilique · 4.8 · 13 or worsening heart or lung disease (see section 4.4). Ticagrelor does not affect tests of pulmonary functio
Eintrag öffnenBrilique · 4.8 · 35 or worsening heart or lung disease (see section 4.4). Ticagrelor does not affect tests of pulmonary functio
Eintrag öffnenBrimica Genuair · 4.3 · Hypersensitivity to the active substances or to the excipient listed in section 6.1.
Eintrag öffnenBrinavess · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Patients with
Eintrag öffnenBrineura · 4.3 · Life-threatening anaphylactic reaction to the active substance or to any of the excipients listed in section 6
Eintrag öffnenBrineura · 4.8 · The adverse reactions described in this section were evaluated in 38 patients with CLN2 disease who received a
Eintrag öffnenBrintellix · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBrintellix · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBriumvi · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Severe active
Eintrag öffnenBronchitol · 4.3 · Bronchial hyperresponsiveness to inhaled mannitol (see section 4.4).
Eintrag öffnenBrukinsa · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBrukinsa · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBuccolam · 4.3 · Hypersensitivity to the active substance, benzodiazepines or to any of the excipients listed in section 6.1 My
Eintrag öffnenBusulfan Fresenius Kabi · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Pregnancy (see sec
Eintrag öffnenBuvidal · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 Severe respiratory
Eintrag öffnenBuvidal · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 Severe respiratory
Eintrag öffnenByooviz · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenByooviz · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenByooviz · 4.5 · For the adjunctive use of laser photocoagulation and ranibizumab in DME and BRVO, see sections 4.2 and 5.1.
Eintrag öffnen